Biovelocita II attracts robust support from leading pharmaceutical companies, including Amgen, Bristol Myers Squibb, and Pfizer Ventures The fund has already screened over 300 projects and made several investments into new companies to catalyze transformative innovation in biotechnology PARIS, France – March 18, 2025 – Sofinnova Partners (“Sofinnova”), a leading European life sciences venture capital […]